Pregabalin for detoxification from opioids: a single case study

References

• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Text Revision. Washington, DC: Author.
   Google Scholar
• Beauchamp, T. L., & Childress, J. F. (2009). Principles of biomedical ethics (6th ed.). Oxford: Oxford University Press.
   Google Scholar
• Bickel, W. K., & Amass, L. A. (1995). Buprenorphine treatment of opioid dependence: A review. Experimental and Clinical Psychopharmacology, 3, 477–489. doi: 10.1037/1064-1297.3.4.477
   Web of Science ®Google Scholar
• Bobes, J., Rubio, G., Cervera, G., Lopez-Gomez, V., Vilardaga, I., & Perez, M. (2012). Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice. European Psychiatry, 27(4), 301–307. doi: 10.1016/j.eurpsy.2010.12.004
   PubMed Web of Science ®Google Scholar
• Bradley, C. (1999). The ethics of good prescribing. In C. Dowrick & L. Frith (Eds.), General practice and ethics: Uncertainty and responsibility (pp. 109–133). London: Routledge.
   Google Scholar
• Brodie, M. J., Wilson, E. A., Wesche, D. L., Alvey, C. W., Randinitis, E. J., Posvar, E. L., … Bockbrader, H. N. (2005). Pregabalin drug interaction studies: Lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia, 46, 1407–1413. doi: 10.1111/j.1528-1167.2005.19204.x
   PubMed Web of Science ®Google Scholar
• Feltner, D. E., Crockatt, J. G., Dubovsky, S. J., Cohn, C. K., Shrivastava, R. K., Targum, S. D., … Pande, A. C. (2003). A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. Journal of Clinical Psychopharmacology, 23(3), 240–249.
   PubMed Web of Science ®Google Scholar
• Flyvbjerg, B. (2006). Five misunderstandings about case-study research. Qualitative Inquiry, 12(2), 219–245. doi: 10.1177/1077800405284363
   Web of Science ®Google Scholar
• Gowing, L., Ali, R., & White, J. (2004). Buprenorphine for the management of opioid withdrawal. Cochrane Database Systematic Review, (4), CD002025.
   Google Scholar
• Gowing, L., Farrell, M., Ali, R., & White, J. (2004). Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Systematic Review, (4), CD002024.
   Google Scholar
• Hulse, G. K., Morris, N., Arnold-Reed, D., & Tait, R. J. (2009). Improving clinical outcomes in treating heroin dependence: Randomized, controlled trial of oral or implant naltrexone. Archives of General Psychiatry, 66(10), 1108–1115. doi: 10.1001/archgenpsychiatry.2009.130
   PubMed Web of Science ®Google Scholar
• Kammerer, N. L., Lemenager, T., Grosshans, M., Kiefer, F., & Hermann, D. (2012). Pregabalin for the reduction of opiate withdrawal symptoms. Psychiatr Prax, 39(7), 351–352. doi: 10.1055/s-0032-1305042
   PubMed Web of Science ®Google Scholar
• Kleber, H. D., Gold, M. S., & Riordan, C. E. (1980). The use of clonidine in detoxification from opiates. Bulletin on Narcotics, 32(2), 1–10.
   PubMedGoogle Scholar
• Kunoe, N., Lobmaier, P., Vederhus, J. K., Hjerkinn, B., Hegstad, S., Gossop, M., … Waal, H. (2009). Naltrexone implants after inpatient treatment for opioid dependence: A randomized controlled trial. British Journal of Psychiatry, 194(6), 541–546. doi: 10.1192/bjp.bp.108.055319
   PubMed Web of Science ®Google Scholar
• Marsch, L. A., Bickel, W. K., Badger, G. J., Stohart, M. E., Quesnel, K. J., Stager, C., & Brooklyn, J. (2005). Comparison of pharmacological treatments for opioid dependent adolescents: A randomised controlled trial. Archives of General Psychiatry, 62(10), 1157–1164. doi: 10.1001/archpsyc.62.10.1157
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. (2007). Drug misuse: Psychosocial interventions. London: Author (NICE clinical guideline 51).
   Google Scholar
• Nicola, M. D., Martinotti, G., Tedeschi, D., Frustaci, A., Mazza, M., Sarchiapone, M., … Janiri, L. (2010). Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Human Psychopharmacology: Clinical & Experimental, 25, 268–275. doi: 10.1002/hup.1098
   PubMed Web of Science ®Google Scholar
• Owen, R. T. (2007). Pregabalin: Its efficacy, safety and tolerability profile in generalized anxiety. Drugs Today, 43, 601–610. doi: 10.1358/dot.2007.43.9.1133188
   PubMed Web of Science ®Google Scholar
• Sandelowski, M. (1986). The problems of rigor in qualitative research. Advances in Nursing Science, 8(3), 27–37. doi: 10.1097/00012272-198604000-00005
   PubMed Web of Science ®Google Scholar
• Sharp, K. (1998). The case for case studies in nursing research: The problem of generalisation. Journal of Advanced Nursing, 27, 785–789. doi: 10.1046/j.1365-2648.1998.00604.x
   PubMed Web of Science ®Google Scholar
• Silverman, D. (2000). Doing qualitative research: A practical handbook. Thousand Oaks, CA: Sage.
   Google Scholar
• Sullivan, J. T., Sykora, K., Schniderman, J., Naranjo, C. A., & Sellers, E. M. (1989). Assessment of alcohol withdrawal: The Revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). British Journal of the Addictions, 84(11), 1353–1357. doi: 10.1111/j.1360-0443.1989.tb00737.x
   PubMedGoogle Scholar
• Tassone, D. M., Boyce, E., Guyer, J., & Nuzum, D. (2007). Pregabalin: A novel gamma-amino-butyric acid analogue in the treatment of neuropathic pain, partial-onset seizures and anxiety disorders. Clinical Therapeutics, 29(1), 26–48. doi: 10.1016/j.clinthera.2007.01.013
   PubMed Web of Science ®Google Scholar
• Taylor, D., Paton, C., & Kerwin, R. (2007). The Maudsley prescribing guidelines (9th ed.). London: Informa Healthcare.
   Google Scholar
• Wesson, D. R., & Ling, W. (2003). The Clinical Opiate Withdrawal Scale (COWS). Journal of Psychoactive Drugs, 35(2), 253–259. doi: 10.1080/02791072.2003.10400007
   PubMed Web of Science ®Google Scholar
• World Health Organisation. (2009). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines. Geneva: Author.
   Google Scholar
• Yin, R. K. (2003). Case study research: Design and methods (3rd ed.). Thousand Oaks, CA: Sage.
   Google Scholar